In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

Koichiro Ogata, Jeanne Mendell‐Harary, Masaya Tachibana et al. · The Journal of Clinical Pharmacology · 2010 · 448 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor

Jean-Luc Martinoli, Léna Leflem, Céline Guinet et al. · Thrombosis and Haemostasis · 2010 · 446 citations

Medicine, Pharmacology, Pharmacotherapy +17

DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles

Taketoshi Furugohri, K. Isobe, Yuko Honda et al. · Journal of Thrombosis and Haemostasis · 2008 · 300 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +5

Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies

Pancras C. Wong, Earl J. Crain, Bailong Xin et al. · Journal of Thrombosis and Haemostasis · 2008 · 299 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement

Alexander T. Cohen, Bengt I. Eriksson, David Puskas et al. · Thrombosis and Haemostasis · 2010 · 146 citations

Medicine, Pharmacology, Pharmacotherapy +17